As populations age and rates of non-communicable diseases rise across all demographics, adult immunization represents a high-impact and cost-effective investment in economic growth and societal resilience – delivering an average return on investment of 19 to 1.

Advances in vaccine science continue to enhance protection for adult populations against a wider range of vaccine preventable diseases, offering governments new tools to strengthen economic resilience and public health. By safeguarding workforce productivity, strengthening fiscal stability and enhancing economic competitiveness, adult immunization programs equip policy decision-makers with a proven tool to support sustainable growth.

Yet systematic underinvestment persists, leaving economies exposed to avoidable costs, fiscal volatility and lost output. Decisive policy action is needed to prioritize adult immunization within national budgets, allowing governments to invest in healthy longevity.

This two-pager outlines four policy recommendations to ensure adult immunization is prioritized within national budgets.